Works matching IS 03407004 AND DT 2017 AND VI 66 AND IP 10
Results: 13
A phase II study of ipilimumab plus temozolomide in patients with metastatic melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 10, p. 1359, doi. 10.1007/s00262-017-2030-y
- By:
- Publication type:
- Article
Blockade of CD112R and TIGIT signaling sensitizes human natural killer cell functions.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 10, p. 1367, doi. 10.1007/s00262-017-2031-x
- By:
- Publication type:
- Article
Intralesional interleukin-2 for unresectable mucosal melanoma refractory to nivolumab.
- Published in:
- 2017
- By:
- Publication type:
- Letter
Decreased human leukocyte antigen A*02:01 frequency is associated with risk of glioma and existence of human cytomegalovirus: a case-control study in Northern China.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 10, p. 1265, doi. 10.1007/s00262-017-2018-7
- By:
- Publication type:
- Article
A gene polymorphism in PD-L1 promoter region is not associated with PD-L1 expression and patients' survival in gastric cancer.
- Published in:
- 2017
- By:
- Publication type:
- Letter
Macrophage-derived interleukin-1beta promotes human breast cancer cell migration and lymphatic adhesion in vitro.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 10, p. 1287, doi. 10.1007/s00262-017-2020-0
- By:
- Publication type:
- Article
CD45RAFoxp3 regulatory T cells have a negative impact on the clinical outcome of head and neck squamous cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 10, p. 1275, doi. 10.1007/s00262-017-2021-z
- By:
- Publication type:
- Article
In vitro differentiated plasmacytoid dendritic cells as a tool to induce anti-leukemia activity of natural killer cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 10, p. 1307, doi. 10.1007/s00262-017-2022-y
- By:
- Publication type:
- Article
Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 10, p. 1249, doi. 10.1007/s00262-017-2025-8
- By:
- Publication type:
- Article
Peripheral blood T cell alterations in newly diagnosed diffuse large B cell lymphoma patients and their long-term dynamics upon rituximab-based chemoimmunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 10, p. 1295, doi. 10.1007/s00262-017-2026-7
- By:
- Publication type:
- Article
Phase I trial of antigen-targeted autologous dendritic cell-based vaccine with in vivo activation of inducible CD40 for advanced prostate cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 10, p. 1345, doi. 10.1007/s00262-017-2027-6
- By:
- Publication type:
- Article
Enhanced stimulation of human tumor-specific T cells by dendritic cells matured in the presence of interferon-γ and multiple toll-like receptor agonists.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 10, p. 1333, doi. 10.1007/s00262-017-2029-4
- By:
- Publication type:
- Article
TGF-β1-silenced leukemia cell-derived exosomes target dendritic cells to induce potent anti-leukemic immunity in a mouse model.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 10, p. 1321, doi. 10.1007/s00262-017-2028-5
- By:
- Publication type:
- Article